Women's Wellness brand NUA Raises Rs 35 Crore in Pre-Series C led by Mirabilis Investment Trust

▴ Nua
Round also saw participation from notable investors including Samir Singh, EVP - Asia, Colgate Palmolive & Former Chair of Unilever SE Asia, Shuchi Kothari, Head of DSP Family Office and SRF Limited.
  • Company turned profitable in Q2 FY24-25 and crossed Rs. 100 Cr net revenue ARR in Q3
  • Company aims to clock Rs. 150 Cr net revenue ARR in the next quarter. 
  • Funds raised will be deployed for retail expansion and new product introduction across key channels
  • Nua, A new age women’s wellness brand offers a wide range of products ranging from toxic-free sanitary pads to period panties, intimate hygiene products, cramp-care solutions, post-partum care and products to manage cyclical acne and more

 

Mumbai, Feb 6, 2025: Women’s wellness and hygiene brand Nua has raised Rs 35 crore in a pre series C round led by Mirabilis Investment Trust. The round also saw participation from distinguished investors including Samir Singh, EVP - Asia, Colgate Palmolive & Former Chair of Unilever SE Asia, Shuchi Kothari, Head of DSP Family Office and SRF Limited. The funds raised will be strategically deployed towards retail expansion and new product introductions across key channels such as marketplaces, quick commerce and offline retail. The Company has raised $21.5 million so far (including the current round) from leading investors including Lightbox VC (One of the earliest backers of Nua), Kae Capital, renowned actress Deepika Padukone and former Global President of Unilever, Vindi Banga.

Ravi Ramachandran, CEO & Co-founder, Nua says, “The past 12 months have been exceptional for Nua. Not only have we turned profitable but we have also grown over 2.5x in revenue. We reached an important milestone by becoming profitable in Q2, crossed Rs. 100 Cr net revenue ARR in Q3 and are now on track to reach Rs. 150 Cr net revenue ARR in the next quarter. The capital raised in the current round will accelerate our journey to achieving the growth milestones we have set for ourselves.” 

Nua’s focus is on building a superlative and holistic experience for women with safe and high-quality products, engaging content and strong community have helped it differentiate in a large and growing space. This success has been driven by word-of-mouth and incredible customer loyalty. The Company will continue investing in new products, content and emerging channels to accelerate this momentum over the next 6-8 quarters, he adds.

Over the last 12 months, the company has added new product segments with a focus on comfort and toxic-free positioning – Extra Long Night Pads, Disposable period panties, menstrual cups and post-partum products. Nua’s products are available on their website and on various ecommerce platforms such as Zepto, Amazon, Flipkart and others.

Commenting on the fund raise, Srinivas Seshadri, Head of Investments at Mirabilis Investment Trust., says, “We look forward to a great journey with Nua in reshaping the menstrual health landscape in our country. The team has demonstrated exceptional growth and a clear path to sustained profitability, while serving a greater purpose—normalizing conversations around menstrual health, offering holistic solutions and empowering women with better choices. Nua’s broad product portfolio and strong presence across channels position it very well to serve a growing tribe of women seeking exceptional performance, value and convenience.”

The Global Feminine Hygiene Products Market size is expected to be worth around USD 66.7 Bn by 2033, from USD 31.8 Bn in 2023, growing at a CAGR of 7.7% during the forecast period from 2024 to 2033. Additionally, India Sanitary Napkin Market Size is projected to grow from USD 1.05 Billion in 2025 to USD 2.59 Billion by 2034, exhibiting a compound annual growth rate (CAGR) of 10.6% during the forecast period (2025-2034)

About Nua

As a fast-growing, new-age brand, Nua is India’s largest and most engaged digital-first women’s wellness company, committed to developing holistic and personalized solutions for the real challenges women face. Starting with innovative, toxic-free sanitary pads, the company has now expanded their product range to period panties, intimate hygiene products, cramp-care solutions, post-partum care and products to manage cyclical acne.

Tags : #

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-



Trending Now

Healthcare Trends in 2026: What India's Doctors, Hospitals, and Patients Need to KnowJuly 18, 2026
Monsoon Health Problems in India: Understanding the Risks, Symptoms, and PreventionJuly 18, 2026
Fortis Escorts Faridabad Launches Faridabad’s First Comprehensive Lung Failure Clinic for Advanced Respiratory and Transplant CareJuly 17, 2026
What Seemed Like Persistent Gas Turned Out To Be A 30-cm Rare Cancer Occupying Most Of Her AbdomenJuly 17, 2026
Kidney Stone Prevention Initiative Unites More Than 8,200 Doctors Across India, Earns Asia Book of Records RecognitionJuly 17, 2026
Moscow radiologists introduce AI tool for hip dysplasia diagnosisJuly 17, 2026
Sharrp Ventures leads 100 CR investment in Naturis Cosmetics’ first institutional funding roundJuly 17, 2026
Eugenix Challenges Hair Loss Stigma With Nationwide 'I Chose Transformation' Campaign Featuring Boney KapoorJuly 17, 2026
How Artificial Intelligence is Reshaping Preventive Healthcare Through Earlier Detection and Smarter Clinical InsightsJuly 17, 2026
Five Common Myths About Children's Urinary Problems That Parents Should Stop BelievingJuly 17, 2026
Robotics in Surgery: How Robot-Assisted Procedures Are Transforming Healthcare in IndiaJuly 17, 2026
Wearable Health Devices: How Smart Technology Is Changing Healthcare in IndiaJuly 17, 2026
Sankara Eye Hospitals Successfully Hosts 20th Annual VISION 2020 India Conference, Celebrating 50 Years of the Sankara MovementJuly 16, 2026
Manipal Hospital Bhubaneswar Successfully Treats Rare Brain Injury Caused by Post-Traumatic Workplace AccidentJuly 16, 2026
Immuneel Therapeutics and Tata Memorial Centre Sign Strategic MoU to Advance Cell and Gene Therapy Research in India July 16, 2026
Breast Cancer Early Warning Signs: What Every Woman in India Needs to KnowJuly 16, 2026
HbA1c Test Explained: What It Measures, Normal Range, and Why It Matters for IndiansJuly 16, 2026
Not Just Weight Loss: How Bariatric Surgery Improves Diabetes, PCOS, and Thyroid-Related Health ChallengesJuly 15, 2026
Leiutis Pharmaceuticals announces CDSCO approval for Global-First Synthetic CBD Therapy for Mild to Moderate Anxiety DisordersJuly 15, 2026
Dr Agarwals Institute of Optometry and SASTRA University Jointly Launch Optometry ProgrammeJuly 15, 2026